Drug intelligence / Profile preview

iodine-131 iodized oil

Development stage
Unknown
Lead developer
Guerbet
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intra-arterial
01

Overview

Iodine-131 iodized oil, also known as 131I-Lipiodol, is a radiopharmaceutical primarily used for the treatment of hepatocellular carcinoma (HCC). It is a combination of the radioactive isotope iodine-131 and iodized oil, which consists of iodinated ethyl esters of fatty acids derived from poppy seed oil (Lipiodol). The iodized oil component exhibits a high affinity for fatty acid-containing tissues, leading to its selective accumulation within HCC tissues due to their rich vascularity and lipophilic nature. Once localized in the tumor, the iodine-131 emits beta electrons (β-), which exert cytotoxic effects on tumor cells, delivering targeted radiation and minimizing exposure to surrounding healthy tissues. Although it was previously withdrawn from some markets due to observed lung toxicity, it has since re-entered the market in regions such as India and Brazil.

Brand names
Lipiocis
Other names
131I-LipiodolI-131 LipiodolI131 LipiodolI 131 Lipiodol131I-Ethiodized Oil
02

Targets

DNA

Beyond the preview

Go deeper on iodine-131 iodized oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iodine-131 iodized oil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call